Abstract
Most patients with active vitiligo (82% of 61) have antibodies to antigens of normal human melanocytes that can be detected by specific immunoprecipitation of radioiodinated, detergent-soluble, melanocyte macromolecules. Such antibodies were present in only 12% of patients with melanoma and in none of 35 patients with nonpigmentary skin diseases. The antibodies were directed to a common antigen(s) on melanocytes that was not present on normal fibroblasts or keratinocytes. These observations suggest that vitiligo is an autoimmune disease mediated by antibodies to melanocyte-associated antigen(s).
Full Text
The Full Text of this article is available as a PDF (504.5 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Betterle C., Peserico A., Bersani G. Vitiligo and autoimmune polyendocrine deficiencies with autoantibodies to melanin-producing cells. Arch Dermatol. 1979 Mar;115(3):364–364. [PubMed] [Google Scholar]
- Eisinger M., Lee J. S., Hefton J. M., Darzynkiewicz Z., Chiao J. W., de Harven E. Human epidermal cell cultures: growth and differentiation in the absence of differentiation in the absence of dermal components or medium supplements. Proc Natl Acad Sci U S A. 1979 Oct;76(10):5340–5344. doi: 10.1073/pnas.76.10.5340. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eisinger M., Marko O. Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. Proc Natl Acad Sci U S A. 1982 Mar;79(6):2018–2022. doi: 10.1073/pnas.79.6.2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Heaney-Kieras J., Bystryn J. C. Identification and purification of a Mr 75,000 cell surface human melanoma-associated antigen. Cancer Res. 1982 Jun;42(6):2310–2316. [PubMed] [Google Scholar]
- Hertz K. C., Gazze L. A., Kirkpatrick C. H., Katz S. I. Autoimmune vitiligo: detection of antibodies to melanin-producing cells. N Engl J Med. 1977 Sep 22;297(12):634–637. doi: 10.1056/NEJM197709222971204. [DOI] [PubMed] [Google Scholar]
- Howanitz N., Nordlund J. L., Lerner A. B., Bystryn J. C. Antibodies to melanocytes. Occurrence in patients with vitiligo and chronic mucocutaneous candidiasis. Arch Dermatol. 1981 Nov;117(11):705–708. doi: 10.1001/archderm.117.11.705. [DOI] [PubMed] [Google Scholar]
- LANGHOF H., FEUERSTEIN M., SCHABINSKI G. MELANINANTIKOERPERBILDUNG BEI VITILIGO. Hautarzt. 1965 May;16:209–212. [PubMed] [Google Scholar]
- Lerner A. B., Nordlund J. J. Vitiligo. What is it? Is it important? JAMA. 1978 Mar 20;239(12):1183–1187. doi: 10.1001/jama.239.12.1183. [DOI] [PubMed] [Google Scholar]
- Phillips D. R., Morrison M. Exposed protein on the intact human erythrocyte. Biochemistry. 1971 May 11;10(10):1766–1771. doi: 10.1021/bi00786a006. [DOI] [PubMed] [Google Scholar]
- Woolfson H., Finn O. A., Mackie R. M., McQueen A., MacSween R. N. Serum anti-tumour antibodies and auto-antibodies in vitiligo. Br J Dermatol. 1975 Apr;92(4):395–400. doi: 10.1111/j.1365-2133.1975.tb03099.x. [DOI] [PubMed] [Google Scholar]